STOKE THERAPEUTICS INC's ticker is and the CUSIP is 86150R907. A total of 3 filers reported holding STOKE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37 | -67.8% | 9,600 | -11.9% | 0.00% | – |
| Q2 2023 | $115 | +2200.0% | 10,900 | +1457.1% | 0.00% | – |
| Q1 2023 | $5 | -100.0% | 700 | +23233.3% | 0.00% | – |
| Q1 2021 | $11,000 | -91.9% | 3 | -86.4% | 0.00% | – |
| Q4 2020 | $136,000 | +115.9% | 22 | +15.8% | 0.00% | – |
| Q3 2020 | $63,000 | +21.2% | 19 | -13.6% | 0.00% | – |
| Q2 2020 | $52,000 | – | 22 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 700 | $17,000 | 0.00% |
| SIMPLEX TRADING, LLC | 22 | $52,000 | 0.00% |
| JPMORGAN CHASE & CO | 8,300 | $198,000 | 0.00% |